MUSTANG BIO, INC. (MBIO) Operating cash flow 2016–2025
MUSTANG BIO, INC. (MBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.3MFY2025 · since FY2016: -$4.1M → -$5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.3M | +53.9% |
| FY2024 | -$11.4M | +76.9% |
| FY2023 | -$49.5M | +24.0% |
| FY2022 | -$65.1M | -21.2% |
| FY2021 | -$53.7M | -43.8% |
| FY2020 | -$37.3M | -11.1% |
| FY2019 | -$33.6M | -74.5% |
| FY2018 | -$19.2M | -48.6% |
| FY2017 | -$12.9M | -213.6% |
| FY2016 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MBIO financial trends
MBIO RevenueMBIO Net incomeMBIO Net marginMBIO Gross profitMBIO Gross marginMBIO Operating incomeMBIO Operating marginMBIO Free cash flowMBIO Capital expendituresMBIO Return on equityMBIO Stock buybacksMBIO Dividends paidMBIO Total assetsMBIO Total liabilitiesMBIO Shareholders’ equityMBIO overview →